Close Menu

This story has been updated with additional information from Abbott's earnings call. 

NEW YORK – Abbott on Thursday said that its Diagnostics business revenues grew 5 percent year over year in the second quarter, while its total revenues were down 8 percent.

For the three months ended June 30, the Abbott Park, Illinois-based firm reported overall Q2 revenues of $7.33 billion, down from $7.98 billion in Q2 2019, and down 5 percent on an organic basis. The company beat the consensus Wall Street estimate of $6.75 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.